Introduction Adults aged 18–64 years comprise most of the working population, meaning
that influenza infection can be disruptive, causing prolonged absence from the workplace …

The development of preventive and therapeutic vaccines has played a crucial role in
preventing infections and treating chronic and non-communicable diseases, respectively …

Introduction Influenza remains a significant global public health challenge, causing
substantial morbidity and mortality worldwide. Despite the availability of influenza vaccines …

Seasonal influenza is an acute respiratory infection caused by the influenza virus which
constitutes a significant public health issue associated with high morbidity and mortality. The …

Background: Patients with cancer present a higher risk of vaccine-preventable diseases.
Recommended vaccinations are the most cost-effective measure to reduce the risk of …

Introduction This paper summarizes the safety and immunogenicity data of Influvac Tetra
across all age groups starting from 6 months of age, obtained during its clinical development …

Abstract Background In Europe, flu vaccination coverage has decreased, and there are
complex barriers to overcome to vaccinate against flu. Many studies have been conducted to …

Introduction Vaccination is one of the most effective population strategies to prevent
infectious diseases and mitigate pandemics, and it is important to understand vaccine …

Recent advancements in in vitro transcribed mRNA (IVT-mRNA) vaccine manufacturing
have attracted considerable interest as advanced methods for combating viral infections …

Background: Influenza vaccination is essential for type 2 diabetes mellitus (T2DM) patients
due to their higher risks of severe complications and mortality from influenza. This study …